Purchase Order 75D30122P13540
Award Date 3/23/22
Potential Completion Date 4/22/22
Potential Value $204K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84116, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $174,160.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostic testing products, for the provision of CBOT singleplex assays and related laboratory supplies. This contract does not have a set-aside designation. XCR Diagnostics, Inc. is a subsidiary of Fluoresentric, Inc., another manufacturer of goods. The contract, awarded out of the CDC's...
- This $151,410.00 firm fixed price purchase order was awarded to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing products, by the Centers for Disease Control and Prevention (CDC) out of Pittsburgh, Pennsylvania. The contract is for the delivery of laboratory supplies including CBOT singleplex assays, which are used for disease diagnostic testing. This purchase order is not associated with any larger contract vehicle and does not have a set-aside designation. XCR...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to XCR Diagnostics, Inc., a manufacturer of goods focused on molecular diagnostics testing. The $147,000.00 contract is for the delivery of CBOT singleplex assays, laboratory supplies, and reagents to support the CDC's diagnostic testing capabilities in Pittsburgh, Pennsylvania and Atlanta, Georgia. The contract has a completion date of August 1, 2019...
- XCR Diagnostics, Inc., a subsidiary of Fluoresentric, Inc., has been awarded a purchase order contract valued at two hundred eleven thousand seven hundred seventy-one dollars by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of a singleplex CBOT A assay to CDC's facility in Atlanta, Georgia. The firm fixed price contract runs from September 12, 2023 through October 30, 2023. No set aside designation or subcontractors...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Fluoresentric, Inc., a manufacturer of goods registered to receive federal government awards. The contract, valued at $207,900.00, is for the provision of CBOT singleplex assays, which are laboratory reagents and diagnostic testing materials that support the CDC's mission of disease control and prevention. The contract has a firm fixed price pricing type and a performance period ending on August 7,...
- The Centers for Disease Control and Prevention (CDC) awarded a $77,468.82 firm fixed price purchase order to Luminex Corporation for MAGPIX and reagent lab supplies. The CDC, located within the Department of Health and Human Services, will utilize these products to support its infectious disease prevention and control programs conducted from its Pittsburgh location. Luminex will deliver the requested supplies from its production facilities in Austin, Texas by October 27, 2023 to meet the CDC's...
- This definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to purchase reagents and consumables for approximately $59,500. The CDC, a component of the Department of Health and Human Services, seeks to protect public health and safety through the control and prevention of disease, injury, and disability. This firm fixed price contract supports the CDC's mission and is being performed in Chamblee, Georgia through August 1, 2023. No set...
- The Centers for Disease Control and Prevention (CDC) awarded Illumina, Inc. a $160,535.84 firm fixed price purchase order for reagents. The CDC, part of the Department of Health and Human Services, will utilize the reagents in Pittsburgh, Pennsylvania as part of its efforts to advance public health. Illumina will deliver the products from its facilities in San Diego, California by September 30, 2023 to support the CDC's disease prevention and health promotion activities. No set aside designation...
- The Centers for Disease Control and Prevention (CDC) awarded a $144,511 purchase order to Roche Diagnostics Corporation for reagents and laboratory supplies. As the prime contractor, Roche will provide the requested products to support CDC's disease prevention and health promotion efforts. The firm fixed price contract has a one year period of performance starting in September 2023. No subcontractors or set aside designations were indicated. The award falls under HHS-CDC's broader public...
- The Centers for Disease Control and Prevention (CDC) awarded a $8,905.97 firm fixed price purchase order to Tecan U.S., Inc. for laboratory equipment. As part of the Department of Health and Human Services (HHS), the CDC works to protect public health and safety through control and prevention of disease, injury, and disability. The equipment will support the CDC's work at its Pittsburgh location and will be delivered to Atlanta, Georgia by September 30, 2023. Tecan will serve as the prime...